134 related articles for article (PubMed ID: 24851524)
1. Non-alcoholic fatty liver disease among visitors to a hepatitis awareness programme.
Abbas Z; Saeed A; Hassan SM; Luck NH; Khan A; Zafar MN; Hossain KZ; Faiq SM
Trop Gastroenterol; 2013; 34(3):153-8. PubMed ID: 24851524
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.
Lobstein S; Kaiser T; Liebert U; Wojan M; Leichtle A; Mössner J; Wiegand J; Tillmann HL
Z Gastroenterol; 2008 May; 46(5):415-20. PubMed ID: 18461515
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community.
Onyekwere CA; Ogbera AO; Balogun BO
Ann Hepatol; 2011; 10(2):119-24. PubMed ID: 21502672
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).
Tasneem AA; Luck NH; Majid Z
Trop Doct; 2018 Apr; 48(2):107-112. PubMed ID: 29145775
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
[TBL] [Abstract][Full Text] [Related]
7. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
[TBL] [Abstract][Full Text] [Related]
9. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
10. Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus.
Chang WY; Chen CJ; Lu SN; You SL; Chuang WL; Chen SC; Su WP; Wang LY; Hsieh MY; Wu MM
J Gastroenterol Hepatol; 1992; 7(5):455-8. PubMed ID: 1382655
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China.
Zhang H; He SM; Sun J; Wang C; Jiang YF; Gu Q; Feng XW; Du B; Wang W; Shi XD; Zhang SQ; Li WY; Niu JQ
Int J Med Sci; 2011 Mar; 8(3):254-62. PubMed ID: 21487569
[TBL] [Abstract][Full Text] [Related]
12. Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors?
Almobarak AO; Barakat S; Khalifa MH; Elhoweris MH; Elhassan TM; Ahmed MH
Arab J Gastroenterol; 2014 Mar; 15(1):12-5. PubMed ID: 24630507
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
[TBL] [Abstract][Full Text] [Related]
14. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes.
Jamali R; Khonsari M; Merat S; Khoshnia M; Jafari E; Bahram Kalhori A; Abolghasemi H; Amini S; Maghsoudlu M; Deyhim MR; Rezvan H; Pourshams A
World J Gastroenterol; 2008 May; 14(18):2867-71. PubMed ID: 18473412
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of non alcoholic fatty liver and Non alcoholic Steatohepatitis in Peshawar Cantonment, Khyber Pakhtunkhwa, Pakistan.
Shah AS; Khan S; Rahim H; Chishti KA; Khan AG
Pak J Pharm Sci; 2018 Jan; 31(1):193-198. PubMed ID: 29348103
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
[TBL] [Abstract][Full Text] [Related]
19. The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
Kim KS; Oh HJ; Kim DJ; Kim SK; Park SW; Cho YW; Huh KB
Endocr J; 2013; 60(12):1295-301. PubMed ID: 24047563
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
